Director/PDMR Shareholding
Updated : 07:07
London, 2 January 2020
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | David Morrison | ||||||
2. | Reason for the notification | |||||||
a) | Position / status | Director of Georgia Healthcare Group PLC / PDMR | ||||||
b) | Initial notification / amendment | Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Georgia Healthcare Group PLC | ||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument
Identification Code
| ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||
b) | Nature of the transaction | Disposal of ordinary shares in exchange for shares in Georgia Capital PLC through the Exchange Facility set up by Georgia Capital PLC at the share exchange ratio of 0.192; 1 share in Georgia Capital PLC for every 5.22 shares in Georgia Healthcare Group PLC. | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information |
| ||||||
| Aggregated volume
| 51,017 ordinary shares | ||||||
| Aggregated price | N/A | ||||||
|
|
| ||||||
e) | Date of the transactions | 27 December 2019 | ||||||
f)
| Place of the transaction | London Stock Exchange (XLON) | ||||||
|
|
|
|
|
Name of authorised official of issuer responsible for making notification:
Link Company Matters Limited, Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.